The comparative in vitro activity of ofloxacin (RU 43 280) and other quinolone derivatives against 722 bacteria of clinical interest.
Santos Ferreira
M
M
Department of Microbiology, Faculty of Pharmacology, University of Lisbon, Portugal.
Vital
J
J
D001419:Bacteria / Q000187:drug effects* / Q000302:isolation & purification; D001441:Bacteroides fragilis / Q000187:drug effects; D003016:Clostridium perfringens / Q000187:drug effects; D004755:Enterobacteriaceae / Q000187:drug effects; D005673:Fusobacterium / Q000187:drug effects; D006094:Gram-Positive Bacteria / Q000187:drug effects; D006801:Humans; D008826:Microbial Sensitivity Tests; D009268:Nalidixic Acid / Q000494:pharmacology*; D009643:Norfloxacin / Q000494:pharmacology*; D015242:Ofloxacin / Q000494:pharmacology*; D013329:Structure-Activity Relationship
D009268:Nalidixic Acid; D015242:Ofloxacin; D009643:Norfloxacin